{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:04:44Z","timestamp":1784106284760,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":95,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007911","name":"UCSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA285997"],"award-info":[{"award-number":["R01CA285997"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P42ES010337"],"award-info":[{"award-number":["P42ES010337"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA029019"],"award-info":[{"award-number":["AA029019"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA028550"],"award-info":[{"award-number":["AA028550"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA011999"],"award-info":[{"award-number":["AA011999"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R56DK088837"],"award-info":[{"award-number":["R56DK088837"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK091183"],"award-info":[{"award-number":["DK091183"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK099205"],"award-info":[{"award-number":["DK099205"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK120515"],"award-info":[{"award-number":["DK120515"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK111866"],"award-info":[{"award-number":["R01DK111866"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK101737"],"award-info":[{"award-number":["DK101737"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R44DK115242"],"award-info":[{"award-number":["R44DK115242"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.jcmgh.2026.101785","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:36:33Z","timestamp":1775896593000},"page":"101785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mesothelin\/Mucin 16 Signaling in Activated Portal Fibroblasts Drives the Development of Cholestatic Fibrosis and Hepatocellular Carcinoma in Aged Female Multidrug Resistance Protein 2 Knockout Mice"],"prefix":"10.1016","volume":"20","author":[{"given":"Sadatsugu","family":"Sakane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Fuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Miciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Diggle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonseok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9107-2306","authenticated-orcid":false,"given":"Tatiana","family":"Kisseleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2026.101785_bib1","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3390\/ijms20071723","article-title":"The role of fibrosis and liver-associated fibroblasts in the pathogenesis of hepatocellular carcinoma","volume":"20","author":"Baglieri","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2026.101785_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jhep.2022.10.007","article-title":"Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases\u2020","volume":"78","author":"Nevens","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101785_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jcmgh.2026.101785_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101785_bib5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jhep.2019.04.012","article-title":"Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice","volume":"71","author":"Nishio","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101785_bib6","first-page":"265","article-title":"Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat","volume":"74","author":"Tuchweber","year":"1996","journal-title":"Lab Invest"},{"key":"10.1016\/j.jcmgh.2026.101785_bib7","doi-asserted-by":"crossref","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","article-title":"Origin of myofibroblasts in the fibrotic liver in mice","volume":"111","author":"Iwaisako","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2026.101785_bib8","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1172\/JCI88845","article-title":"Mesothelin\/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcmgh.2026.101785_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101270118","article-title":"Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis","volume":"118","author":"Nishio","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2026.101785_bib10","first-page":"1237","article-title":"Mice with homozygous disruption of the mdr2 P-glycoprotein gene. a novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis","volume":"145","author":"Mauad","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2026.101785_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ajpath.2014.10.013","article-title":"A new Mdr2(-\/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer","volume":"185","author":"Ikenaga","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2026.101785_bib12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0168-8278(97)80020-7","article-title":"The role of bile salt composition in liver pathology of mdr2 (-\/-) mice: differences between males and females","volume":"26","author":"van Nieuwerk","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101785_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.761255","article-title":"The pathological mechanisms of estrogen-induced cholestasis: current perspectives","volume":"12","author":"Zu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcmgh.2026.101785_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1194\/jlr.M088070","article-title":"Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2-\/- mice","volume":"60","author":"Wang","year":"2019","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jcmgh.2026.101785_bib15","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/ncb2610","article-title":"Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature","volume":"14","author":"Rinkevich","year":"2012","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jcmgh.2026.101785_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/biomedicines9040397","article-title":"Mesothelin expression in human tumors: a tissue microarray study on 12,679 tumors","volume":"9","author":"Weidemann","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jcmgh.2026.101785_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.7150\/jca.1.141","article-title":"Mesothelin as a potential therapeutic target in human cholangiocarcinoma","volume":"1","author":"Yu","year":"2010","journal-title":"J Cancer"},{"key":"10.1016\/j.jcmgh.2026.101785_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hep.29464","article-title":"Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2-\/-) mice","volume":"67","author":"Moncsek","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101785_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ccell.2021.05.010","article-title":"Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations","volume":"39","author":"Affo","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcmgh.2026.101785_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/jhep.2003.50067","article-title":"DNase I-hypersensitive sites enhance alpha1(I) collagen gene expression in hepatic stellate cells","volume":"37","author":"Yata","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101785_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.111.096172","article-title":"DAN (NBL1) specifically antagonizes BMP2 and BMP4 and modulates the actions of GDF9, BMP2, and BMP4 in the rat ovary","volume":"86","author":"Hung","year":"2012","journal-title":"Biol Reprod"},{"key":"10.1016\/j.jcmgh.2026.101785_bib22","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jhep.2022.07.029","article-title":"Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling","volume":"77","author":"Rosenberg","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101785_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101785_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep4.1023","article-title":"Portal fibroblasts marked by the surface antigen Thy1 contribute to fibrosis in mouse models of cholestatic liver injury","volume":"1","author":"Katsumata","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jcmgh.2026.101785_bib25","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-03-0801","article-title":"Mesothelin: a new target for immunotherapy","volume":"10","author":"Hassan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcmgh.2026.101785_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/bs.acr.2022.01.013","article-title":"Immunotherapy for hepatobiliary cancers: emerging targets and translational advances","volume":"156","author":"Li","year":"2022","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.jcmgh.2026.101785_bib27","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ajpath.2021.05.019","article-title":"Nondegradable collagen increases liver fibrosis but not hepatocellular carcinoma in mice","volume":"191","author":"Baglieri","year":"2021","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2026.101785_bib28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-022-05169-z","article-title":"Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome","volume":"610","author":"Su","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101785_bib29","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1349-7006.2011.01846.x","article-title":"Deficiency of the Erc\/mesothelin gene ameliorates renal carcinogenesis in Tsc2 knockout mice","volume":"102","author":"Zhang","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jcmgh.2026.101785_bib30","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s41586-025-08677-w","article-title":"Hepatic stellate cells control liver zonation, size and functions via R-spondin 3","volume":"640","author":"Sugimoto","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101785_bib31","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/srep01870","article-title":"Mesothelin binding to CA125\/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation","volume":"3","author":"Chen","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101785_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/jsre.2001.6318","article-title":"TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis","volume":"102","author":"Bloomston","year":"2002","journal-title":"J Surg Res"},{"key":"10.1016\/j.jcmgh.2026.101785_bib33","doi-asserted-by":"crossref","first-page":"8615","DOI":"10.1158\/0008-5472.CAN-07-0232","article-title":"Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling","volume":"67","author":"Kopitz","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2026.101785_bib34","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.cellsig.2006.03.005","article-title":"Hepatocyte growth factor installs a survival platform for colorectal cancer cell invasive growth and overcomes p38 MAPK-mediated apoptosis","volume":"18","author":"Fassetta","year":"2006","journal-title":"Cell Signal"},{"key":"10.1016\/j.jcmgh.2026.101785_bib35","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","article-title":"Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer","volume":"40","author":"Huang","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcmgh.2026.101785_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.186268","article-title":"Affinity-tuned mesothelin CAR T cells demonstrate enhanced targeting specificity and reduced off-tumor toxicity","volume":"9","author":"Yang","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcmgh.2026.101785_bib37","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41591-023-02452-y","article-title":"Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1\/2 trial interim results","volume":"29","author":"Hassan","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2026.101785_bib38","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1128\/MCB.20.8.2902-2906.2000","article-title":"Mesothelin is not required for normal mouse development or reproduction","volume":"20","author":"Bera","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jcmgh.2026.101785_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004675","article-title":"CA125\/MUC16 is dispensable for mouse development and reproduction","volume":"4","author":"Cheon","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2026.101785_bib40","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/379826a0","article-title":"Normal spatial learning despite regional inhibition of LTP in mice lacking Thy-1","volume":"379","author":"Nosten-Bertrand","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101785_bib41","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.3390\/cancers14153670","article-title":"Etiology, pathogenesis, diagnosis, and practical implications of hepatocellular neoplasms","volume":"14","author":"Hytiroglou","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcmgh.2026.101785_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/hep.32586","article-title":"Characterization and role of collagen gene expressing hepatic cells following partial hepatectomy in mice","volume":"77","author":"Kimura","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101785_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102391","article-title":"Isolation of primary human liver cells from normal and nonalcoholic steatohepatitis livers","volume":"4","author":"Liu","year":"2023","journal-title":"STAR Protoc"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26000639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26000639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T08:14:17Z","timestamp":1784103257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X26000639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2352345X26000639"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101785","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesothelin\/Mucin 16 Signaling in Activated Portal Fibroblasts Drives the Development of Cholestatic Fibrosis and Hepatocellular Carcinoma in Aged Female Multidrug Resistance Protein 2 Knockout Mice","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101785"}}